Common Contracts
2 similar Investor Rights Agreement contracts by Armata Pharmaceuticals, Inc.
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 11th, 2022 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 9, 2022 by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), Innoviva, Inc., a Delaware corporation (“Innoviva”), and Innoviva Strategic Opportunities LLC, a Delaware limited liability company and a wholly-owned subsidiary of Innoviva (“Innoviva Sub” and, together with Innoviva, the “Purchasers”), in connection with (i) that certain Securities Purchase Agreement, dated as of January 27, 2020, by and between the Company and Innoviva (“2020 Purchase Agreement”), (ii) that certain Securities Purchase Agreement, dated as of January 26, 2021, by and between the Company and Innoviva Sub (the “2021 Q1 Purchase Agreement”), (iii) that certain Securities Purchase Agreement, dated as of October 28, 2021, by and between the Company and Innoviva Sub (the “2021 Q4 Purchase Agreement”), and (iv) that certain Securities Purchase Agreement, dated as of Februar
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 27th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of January 26, 2021 by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), Innoviva, Inc., a Delaware corporation (“Innoviva”), and Innoviva Strategic Opportunities LLC, a Delaware limited liability company and a wholly-owned subsidiary of Innoviva (“Innoviva Sub” and, together with Innoviva, the “Purchasers”), in connection with (i) that certain Securities Purchase Agreement, dated as of January 27, 2020, by and between the Company and Innoviva (“2020 Purchase Agreement”), and (ii) that certain Securities Purchase Agreement, dated as of January 26, 2021, by and between the Company and Innoviva Sub (the “2021 Purchase Agreement”). This Agreement shall amend and restate in its entirety that certain Investor Rights Agreement dates as of February 12, 2020 (the “Original Agreement”), provided that nothing herein shall relieve any person of any liability with respect to a
